Daniel Schwartzlose

Team

Operations Advisory

Location

Copenhagen

Joined in January 2022. Daniel previously worked at Danish pharmaceutical company Xellia Pharmaceuticals from 2014 to 2021, where he has held several executive positions, and from 2019-2021 was President for Xellia International with responsibility for their activities in EMEA, LATAM and APAC regions. Prior that Daniel worked at LEO Pharma and formerly in consulting with Qvartz (now Bain) and PwC Deals advisory. Daniel holds a Master’s in Economics from University of Copenhagen.

The “Our People” directory reflects those working at Nordic Capital and its independent directors and is updated from time to time. It should not be relied on as evidence of a current employment or other contractual relationship with Nordic Capital. Nordic Capital refers to all or any of the Nordic Capital Products (or the vehicles which they are comprised of), the GPs/DPMs of the Nordic Capital Products, Nordic Capital Management SARL including any branches, Nordic Capital Limited, the Nordic Capital Advisors and/or their respective affiliated entities, as applicable. However, this does not imply from a legal, regulatory or tax perspective, nor should it be inferred, that any of the aforementioned entities are not separate and distinct entities, nor that there is any single Nordic Capital entity. Nordic Capital Advisors is a global group of non-discretionary sub-advisors providing advisory services exclusively to the GPs/DPMs of the Nordic Capital Products and which includes the Nordic Capital Investment Advisory, Evolution Advisory, Operations Advisory and Specialist Functions Advisory teams. The Nordic Capital Operations Advisory team provides operational advisory support in respect of current or prospective portfolio companies of the Nordic Capital Products, the compensation for which is economically borne by the Nordic Capital Products and their investors.